Literature DB >> 34067388

Persistence of Coxsackievirus B4 in Pancreatic β Cells Disturbs Insulin Maturation, Pattern of Cellular Proteins, and DNA Methylation.

Magloire Pandoua Nekoua1, Antoine Bertin1, Famara Sane1, Jean-Pascal Gimeno2, Isabelle Fournier2, Michel Salzet2, Ilka Engelmann1, Enagnon Kazali Alidjinou1, Didier Hober1.   

Abstract

Coxsackievirus-B4 (CV-B4) can persist in pancreatic cell lines and impair the phenoytpe and/or gene expressions in these cells; however, the models used to study this phenomenon did not produce insulin. Therefore, we investigated CV-B4 persistence and its consequences in insulin-producing pancreatic β cells. The insulin-secreting rat β cell line, INS-1, was infected with CV-B4. After lysis of a large part of the cell layer, the culture was still maintained and no additional cytopathic effect was observed. The amount of insulin in supernatants of cell cultures persistently infected with CV-B4 was not affected by the infection; in fact, a larger quantity of proinsulin was found. The mRNA expression of pro-hormone convertase 2, an enzyme involved in the maturation of proinsulin into insulin and studied using real-time reverse transcription-polymerase chain reaction, was inhibited in infected cultures. Further, the pattern of 47 cell proteins analyzed using Shotgun mass spectrometry was significantly modified. The DNA of persistently infected cell cultures was hypermethylated unlike that of controls. The persistent infection of INS-1 cells with CV-B4 had a deep impact on these cells, especially on insulin metabolism. Cellular changes caused by persistent CV-B4 infection of β cells can play a role in type 1 diabetes pathogenesis.

Entities:  

Keywords:  DNA methylation; INS-1 cell line; coxsackievirus B4; in vitro; insulin; pancreatic β cell; persistence; pro-hormone convertase 2; type 1 diabetes

Year:  2021        PMID: 34067388     DOI: 10.3390/microorganisms9061125

Source DB:  PubMed          Journal:  Microorganisms        ISSN: 2076-2607


  60 in total

1.  Visualizing and quantifying the differential cleavages of the eukaryotic translation initiation factors eIF4GI and eIF4GII in the enterovirus-infected cell.

Authors:  Yueh-Ying Hsu; Yu-Ning Liu; Wen-Wen Lu; Szu-Hao Kung
Journal:  Biotechnol Bioeng       Date:  2009-12-15       Impact factor: 4.530

2.  Persistent coxsackievirus B4 infection induces microRNA dysregulation in human pancreatic cells.

Authors:  Ilka Engelmann; Enagnon K Alidjinou; Antoine Bertin; Johann Bossu; Céline Villenet; Martin Figeac; Famara Sane; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2017-06-10       Impact factor: 9.261

3.  Differential effects of three echovirus strains on cell lysis and insulin secretion in beta cell derived lines.

Authors:  Luis Sarmiento; Anya Medina; Kosrat Aziz; Mahesh Anagandula; Eduardo Cabrera-Rode; Malin Fex; Gun Frisk; Corrado M Cilio
Journal:  J Med Virol       Date:  2015-12-15       Impact factor: 2.327

4.  Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution.

Authors:  P E Tam; R P Messner
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Effects on isolated human pancreatic islet cells after infection with strains of enterovirus isolated at clinical presentation of type 1 diabetes.

Authors:  Asma Elshebani; Annika Olsson; Jan Westman; Torsten Tuvemo; Olle Korsgren; Gun Frisk
Journal:  Virus Res       Date:  2006-12-12       Impact factor: 3.303

6.  Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection.

Authors:  Elizabeth V Nguyen; Sina A Gharib; Kristina Crothers; Yu-Hua Chow; David R Park; David R Goodlett; Lynn M Schnapp
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

7.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 8.  Pediatric group B coxsackievirus infections.

Authors:  J R Romero
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

9.  A transplantable insulinoma in the rat.

Authors:  W L Chick; S Warren; R N Chute; A A Like; V Lauris; K C Kitchen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients.

Authors:  Francesco Dotta; Stefano Censini; Astrid G S van Halteren; Lorella Marselli; Matilde Masini; Sabrina Dionisi; Franco Mosca; Ugo Boggi; Andrea Onetti Muda; Stefano Del Prato; John F Elliott; Antonello Covacci; Rino Rappuoli; Bart O Roep; Piero Marchetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

View more
  4 in total

Review 1.  Pathogenesis of Type 1 Diabetes: Established Facts and New Insights.

Authors:  Ana Zajec; Katarina Trebušak Podkrajšek; Tine Tesovnik; Robert Šket; Barbara Čugalj Kern; Barbara Jenko Bizjan; Darja Šmigoc Schweiger; Tadej Battelino; Jernej Kovač
Journal:  Genes (Basel)       Date:  2022-04-16       Impact factor: 4.141

Review 2.  Persistent Enterovirus Infection: Little Deletions, Long Infections.

Authors:  Nora M Chapman
Journal:  Vaccines (Basel)       Date:  2022-05-12

Review 3.  Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus.

Authors:  Magloire Pandoua Nekoua; Enagnon Kazali Alidjinou; Didier Hober
Journal:  Nat Rev Endocrinol       Date:  2022-06-01       Impact factor: 47.564

4.  Early Emergence of 5' Terminally Deleted Coxsackievirus-B3 RNA Forms Is Associated with Acute and Persistent Infections in Mouse Target Tissues.

Authors:  Domitille Callon; Anne-Laure Lebreil; Nicole Bouland; Caroline Fichel; Paul Fornès; Laurent Andreoletti; Fatma Berri
Journal:  Vaccines (Basel)       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.